Vanguard Fiduciary Trust
ATRA icon

Vanguard Fiduciary Trust’s Atara Biotherapeutics ATRA Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$494K Buy
43,036
+9,415
+28% +$75.1K ﹤0.01% 3278
2026
Q1 		$159K Buy
+33,621
New +$205K ﹤0.01% 3582

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust's ATRA Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Atara Biotherapeutics (ATRA) stake by 28% in Q2 2026, buying an estimated $75.1K and bringing the position to 43,036 shares worth $494K. The position accounts for ﹤0.01% of the portfolio, ranked #3278.

Vanguard Fiduciary Trust first reported a position in ATRA in Q1 2026 and has held it in 2 quarters since. 33 funds tracked by Wall St. Rank hold ATRA as of Q2 2026.

  • Vanguard Fiduciary Trust held 43,036 shares of Atara Biotherapeutics worth $494K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 9,415 Atara Biotherapeutics shares in Q2 2026, an estimated $75.1K.
  • Atara Biotherapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3278 holding.
  • Vanguard Fiduciary Trust first reported a position in Atara Biotherapeutics in Q1 2026 and has held it in 2 quarters since.
  • 33 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.